CenterWatch

Home » Clinical Trials » Therapeutic Areas

Therapeutic Areas: Oncology | Nephrology | Urology | Family Medicine
Disease Category: Prostate Cancer
Location: United States, FL

Clinical Trial Details

Overview

Research Study Summary

Metastatic, Androgen-Independent study for patients with Prostate Cancer

Purpose

Phase II study to assess safely, efficacy and tolerability of three doses of a study medication in patients with Metastatic, Androgen-Independent Prostate Cancer

Patient Inclusion Criteria:

  • Males at least 18 years and older
  • Must have confirmed prostate adenocarcinoma with metastatic, progressive disease while on androgen deprivation therapy
  • PSA ≥ 5ng/ml

Patient Exclusion Criteria:

  • Prior chemotherapy for prostate cancer
  • Prior radiation therapy for prostate cancer
  • History of cardiac conditions
  • Prohibited study medications

To Learn more

CW ID: 163751
Date Last Changed: July 24, 2013

Clinical Trial Snapshot

Phase
2
Gender
Male
Age
18 and up
Overall Status
Recruiting
Facility Type
N/A

Contact

Cheryl Ahlstrom, Patient Liaison
South Florida Medical Research
21150 Biscayne Blvd., Suite 300
Aventura, FL 33180
Phone: 305-931-8080
Fax: 305-931-8088

View Map

Research Center Information: South Florida Medical Research

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.